<!DOCTYPE html>
<html class="no-js">
  <head>
    <meta charset="utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <title>ONCOGERIATRIA</title>
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <meta name="description" content="oncogeriatria" />
    <meta name="keywords" content="oncologia, oncogeriatria, medicina" />
    <meta name="author" content="e-oncologia" />

    <link rel="shortcut icon" type="image/png" href="images/logo.png" />

    <link
      href="https://fonts.googleapis.com/css?family=Roboto:400,300,600,400italic,700"
      rel="stylesheet"
      type="text/css"
    />
    <link
      href="https://fonts.googleapis.com/css?family=Montserrat:400,700"
      rel="stylesheet"
      type="text/css"
    />

    <link rel="stylesheet" href="css/animate.css" />
    <link rel="stylesheet" href="css/icomoon.css" />
    <link rel="stylesheet" href="css/bootstrap.css" />
    <link rel="stylesheet" href="css/owl.carousel.min.css" />
    <link rel="stylesheet" href="css/owl.theme.default.min.css" />
    <link rel="stylesheet" href="css/style.css" />
    <script src="js/modernizr-2.6.2.min.js"></script>
  </head>

  <body>
    <div id="ico-page">
      <a href="#" class="js-ico-nav-toggle ico-nav-toggle"><i></i></a>
      <aside
        id="ico-aside"
        role="complementary"
        class="border js-fullheight"
        style="background-image: url(images/BGoscuro.jpg);"
      >
        <p><br /></p>
        <h2 id="ico-logo">
          <a href="index.html"><img src="images/logo.png" height="80"/></a>
        </h2>
        <nav id="ico-main-menu" role="navigation">
          <ul>
            <li>
              <a href="m1A.html"
                ><span class="bgdestacado1">MÓDULO 1</span><br />VALORACIÓN DEL
                ANCIANO CON CÁNCER</a
              >
            </li>
            <ol>
              <li><a href="m1A.html">Introducción</a></li>
              <li><a href="m1B.html">Envejecimiento poblacional</a></li>
              <li><a href="m1C.html">Evaluación del anciano</a></li>
              <li><a href="m1D.html">Valoración geriátrica integral</a></li>
              <li><a href="m1E.html">Herramientas de cribado</a></li>
              <li><a href="m1F.html">Toma de decisiones</a></li>
              <li><a href="m1G.html">Organización de la atención</a></li>
              <li><a href="m1H.html">Resumen</a></li>
              <li>
                <a href="m1I.html"
                  ><span class="bgdestacado2">Bibliografía</span></a
                >
              </li>
            </ol>
            <br />
            <li>
              <a href="m2A.html"
                ><span class="bgdestacado1">MÓDULO 2</span><br />QUIMIOTERAPIA Y
                NUEVOS TRATAMIENTOS</a
              >
            </li>
            <ol>
              <li><a href="m2A.html">Eficacia de la quimioterapia</a></li>
              <li><a href="m2B.html">Terapias dirigidas</a></li>
              <li><a href="m2C.html">Inmunoterapia</a></li>
              <li><a href="m2D.html">Toxicidad en tto. antineoplasico</a></li>
              <li>
                <a href="m2E.html"
                  ><span class="bgdestacado2">Bibliografía</span></a
                >
              </li>
            </ol>
          </ul>
        </nav>
      </aside>

      <div id="ico-main">
        <div class="ico-cabecera">
          <div class="ico-narrow-content animate-box">
            <h4 class="text-center">Valoración del anciano con cáncer</h4>
            <img
              src="images/ICONOabuelito1.png"
              alt=""
              class="img-responsive centrada"
            />
          </div>
        </div>

        <div class="ico-narrow-content">
          <div class="row animate-box" data-animate-effect="fadeInLeft">
            <div class="col-md-12">
              <h3>Bibliografía</h3>

              <p>
                Alibhai SMH, Aziz S, Manokumar T, et al. A comparison of the
                CARG tool, the VES-13, and oncologist judgment in predicting
                grade 3 + toxicities in men undergoing chemotherapy for
                metastatic prostate cancer. J Geriatr Oncol. 2017;8:31-6.
              </p>
              <p>
                Balducci L, Beghe C. The application of the principles of
                geriatric to the management of the older person with cancer.
                Crit Rev Oncol Hematol. 2000;35(3):147-54.
              </p>
              <p>
                Balducci L, Colloca G, Cesari M, et al. Assessment and treatment
                of elderly patients with cancer. Surg Oncol. 2010;19:117-23.
              </p>
              <p>
                Bellera CA, Rainfray M, Mathoulin-Pellisier S, et al. Screening
                older cancer patients: first evaluation of the G-8 geriatric
                screening tool. Ann Oncol. 2012;23(8):2166-72.
              </p>
              <p>
                Boulahssass R, Gonfrier S, Ferrero JM, et al. Predicting early
                death in older adults with cancer. Eur J Cancer. 2018;100:65-74.
              </p>
              <p>
                Brunello A, Basso U, Sacco C, et al. Safety and activity of
                sunitinib in elderly patients (≥ 70 years) with metastatic renal
                cell carcinoma: a multicenter study. Ann Oncol.
                2013;24(2):336-42.
              </p>
              <p>
                Brunello A, Fontana A, Zafferri V, et al. Development of an
                oncological-multidimensional prognostic index (Onco-MPI) for
                mortality prediction in older cancer patients. J Cancer Res Clin
                Oncol. 2016;142(5):1069-77.
              </p>
              <p>
                Caillet P, Canoui-Poitrine F, Vouriot J, et al. Comprehensive
                Geriatric Assessment in the decisión-making process in elderly
                patients with cancer. ELCAPA study. J Clin Oncol.
                2011;29:3636-42.
              </p>
              <p>
                Chirlaque MD, Salmerón D, Galcerán J, et al; the REDCAN Working
                Group. Cancer survival in adult patients in Spain. Results from
                nine population-based cancer registries. Clin Transl Oncol.
                2018;20:201-11.
              </p>
              <p>
                Corre R, Gervais R, Guisier F, et al. Octogenarians with
                EGFR-mutated non-small cell lung cancer treated by
                tyrosine-kinase inhibitor: a multicentric real-world study
                assessing tolerance and efficacy (OCTOMUT study). Oncotarget.
                2018;9(9):8253-62.
              </p>
              <p>
                Corre R, Greillier L, Le Caër H, et al. Use of a comprehensive
                geriatric assessment for the management of elderly patients with
                advanced non-small-cell lung cancer: the phase III Randomized
                ESOGIA-GFPC-GECP 08-02 Study. J Clin Oncol. 2016;34:1476-83.
              </p>
              <p>
                Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for
                multidimensional health problems warranting a geriatric
                assessment in older cancer patients: an update on SIOG
                recommendations. Ann Oncol. 2015;26:288-300.
              </p>
              <p>
                de Glas NA, van de Water W, Engelhardt EG, et al. Validity of
                Adjuvant! Online program in older patients with breast cancer: a
                population-based study. Lancet Oncol. 2014;15:722-29.
              </p>
              <p>
                de Glas NA, Bastiannet E, Engels CC, et al. Validity of the
                online PREDICT tool in older patients with breast cancer: a
                population-based study. Br J Cancer. 2016;114:395-400.
              </p>
              <p>
                Edwards BK, Howe HL, Ries LA, et al. Annual report of the nation
                on the status of cancer, 1973-1999, featuring implications of
                age and aging on U.S. cancer burden. Cancer.
                2002;94(10):2766-92.
              </p>
              <p>
                Extermann M, Boler I, Reich RR, et al. Predicting the risk of
                chemotherapy toxicity in older patients: the Chemotherapy Risk
                Assessment Scale for High-Age Patients (CRASH) score. Cancer.
                2012;118:3377-86.
              </p>
              <p>
                Feliú J, Heredia-Soto V, Gironés R, et al. Can we avoid the
                toxicity of chemotherapy in elderly cancer patients?. Crit Rev
                Oncol Hematol. 2018; 131:16-23.
              </p>
              <p>
                Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence
                and mortality patterns in Europe: estimates for 40 countries and
                25 major cancers in 2018. Eur J Cancer. 2018;103:356-87.
              </p>
              <p>
                Ferrat E, Paillaud E, Laurent M, et al. Predictors of 1-year
                mortality in a prospective cohort of elderly patients with
                cancer. J Gerontol A Biol Sci Med Sci. 2015;70:1148-55.
              </p>
              <p>
                Festen S, Maaike Kok, Hopstaken JS, et al. How to incorporate
                geriatric assessment in clinical decision-making for older
                patients with cancer. An implementation study. J Geriatr Oncol,
                https://doi.org/10.1016/j.jgo.2019.04.006.
              </p>
              <p>
                Flores Ruano T, Cruz Jentoft AJ, González Montalvo JI, et al.
                Geriatric assessment tools in Spanish Geriatric Departments. Rev
                Esp Geriatr Gerontol. 2014;49(5):235-42.
              </p>
              <p>
                Fried TR, Tinetti ME, Iannone L, et al. Health outcome
                prioritization as a tool for decision making among older persons
                with multiple chronic conditions. Arch Intern Med.
                2011;171(20):1854-6.
              </p>
              <p>
                Fried LP, Hall Wj. Editorial: leading on behalf of an aging
                society. J Am Geriatr Soc. 2008;56(10):1791-5.
              </p>
              <p>
                Ghosn M, Ibrahim T, El Rassy E, et al. Abridged geriatric
                assessment is a better predictor of overall survival than the
                Karnofsky Performance Scale and Physical Performance Test in
                elderly patients with cancer. J Geriatr Oncol. 2017;8:128-32.
              </p>
              <p>
                Gironés R, Morilla I, Guillén-Ponce C, et al. Geriatric oncology
                in Spain: survey results and analysis of the current situation.
                Clin Transl Oncol. 2018;20:1087-92.
              </p>
              <p>
                Goodwin JS, Zhang DD, Ostir GV. Effect of depression on
                diagnosis, treatment, and survival of older women with breast
                cancer. J Am Geriatr Soc. 2004;52:106-11.
              </p>
              <p>
                Hamaker ME, Jonker JM, de Rooij SE, et al. Frailty screening
                methods for predicting outcome of a comprehensive geriatric
                assessment in elderly patients with cancer: a systematic review.
                Lancet Oncol. 2012;13:e437-44.
              </p>
              <p>
                Hamaker ME, Schiphorst AH, ten Bokkel Huinink D. et al. The
                effect of a geriatric evaluation on treatment decisions for
                older cancer patients- a systematic review. Acta Oncol.
                2014;53:289-96.
              </p>
              <p>
                Huisman MG, Van Leeuwen BL, Ugolini G, et al. Predicting outcome
                in onco-geriatric surgical patients: screening tools versus the
                comprehensive geriatric assessment. PLoS One. 2014;9(1):e86863.
              </p>
              <p>
                Hurria A, Li D, Hansen K, et al. Distress in older patients with
                cancer. J Clin Oncol. 2009;27:4346-51.
              </p>
              <p>
                Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy
                toxicity in older adults with cancer: a prospective multicenter
                study. J Clin Oncol. 2011;29:3457-65.
              </p>
              <p>
                Jolly TA, Deal AM, Nyrop KA, et al. Geriatric
                assessment-identified deficits in older cancer patients with
                normal performance status. Oncologist. 2015;20:379-85.
              </p>
              <p>
                Karnakis T, Gattás-Vernaglia IF, Saraiva MD, et al. The
                geriatrician’s perspective on practical aspects of the
                multidisciplinary care of older adults with cancer. J Geriatr
                Oncol. 2016;7:341-45.
              </p>
              <p>
                Kalsi T, Babic-Illman G, Ross PJ, et al. The impact of
                comprehensive geriatric assessment interventions on tolerance to
                chemotherapy in older people. Br J Cancer. 2015;112:1435-44.
              </p>
              <p>
                Kanesvaran R, Li H, Koo KN, et al. Analysis of prognostic
                factors of comprehensive geriatric assessment and development of
                a clinical scoring system in elderly Asian patients with cancer.
                J Clin Oncol. 2011;29(27):3620-7.
              </p>
              <p>
                Kenis C, Decoster L, Van Puyvelde K, et al. Performance of two
                geriatric screening tools in older patients with cancer. J Clin
                Oncol. 2014;32(1):19-26.
              </p>
              <p>
                Kenis C, Bron D, Libert Y, et al. Relevance of a systematic
                geriatric screening and assessment in older patients with
                cancer: results of a prospective multicentric study. Ann Oncol.
                2013;24:1306-12.
              </p>
              <p>
                Luciani A, Biganzoli L, Colloca G, et al. Estimating the risk of
                chemotherapy toxicity in older patients with cancer, the role of
                the Vulnerable Elders Survey-13 (VES-13). J Geriatr Oncol.
                2015;6:272-79.
              </p>
              <p>
                Leach CR, Bellizzi KM, Hurria A, et al. Is it my cancer or am i
                just getting older?: Impact of cancer on age-related health
                conditions of older cancer survivors. Cancer.
                2016;122(12):1946-53.
              </p>
              <p>
                Lichtman SM, Wildiers H, Launay-Vacher V, et al. International
                Society of Geriatric Oncology (SIOG) recommendations for the
                adjustment of dosing in elderly cancer patients with renal
                insufficiency. Eur J Cancer. 2007;43:14-34.
              </p>
              <p>
                Lichtman SM, Wildiers H, Chatelut E, et al. International
                Society of Geriatric Oncology Chemotherapy Taskforce: evaluation
                of chemotherapy in older patients- an analysis of the medical
                literature. J Clin Oncol. 2007;25:1832-43.
              </p>
              <p>
                Maggiore RJ, Dale W, Gross CP, et al. Polypharmacy and
                potentially inappropriate medication use in older adults with
                cancer undergoing chemotherapy: effect on chemotherapy-related
                toxicity and hospitalization during treatment. J Am Geriatr Soc.
                2014;62:1505-12.
              </p>
              <p>
                Martínez-Tapia C, Canoui-Poitrine F, Bastuji-Garin S, et al.
                Optimizing the G8 screening tool for older patients with cancer:
                diagnostic performance and validation of a six-item version.
                Oncologist. 2016;21(2):188-95.
              </p>
              <p>
                Martinez-Tapia C, Paillaud E, Liuu E, et al. Prognostic value of
                the G8 and modified-G8 screening tools for multidimensional
                health problems in older patients with cancer. Eur J Cancer.
                2017;83:211-9.
              </p>
              <p>
                Min L, Yon W, Mriano J, et al. The Vulnerable Elders-13 Survey
                5-year predicts functional decline and mortality outcomes in
                older ambulatory care patients. J Am Geriatr Soc.
                2009;57(11):2070-76.
              </p>
              <p>
                Mohile SG, Bylow K, Dale W, et al. A pilot study of the
                vulnerable elders survey-13 compared with the comprehensive
                geriatric assessment for identifying disability in older
                patients with prostate cancer who receive androgen ablation.
                Cancer. 2007;109(4):802-10.
              </p>
              <p>
                Monfardini S, Basso U, Fiduccia P, et al. Can the short
                screening test vlnerable elders survey 13 (VES-13) substitute
                for the time-consuming comprehensive geriatric assessment (CGA)
                to identify vulnerable/frail elderly breast cancer patients?. J
                Clin Oncol. 2010;28(Suppl):15s (absttr 9114).
              </p>
              <p>
                Molina Garrido MJ. Oncogeriatría: una forma de optimizar la
                atención global del paciente anciano con cáncer. Nutr Hosp.
                2016;33(Suppl 1):177.
              </p>
              <p>
                Magnuson A, Allore H, Cohen HJ, et al. Geriatric assessment in
                cancer care: current evidence and potential mechanisms for
                future research. J Geriatr Oncol. 2016;7:242-48.
              </p>
              <p>
                Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics
                and pharmacodynamics: basic principles and practical
                applications. Br J Clin Pharmacol. 2004;57:6-14.
              </p>
              <p>
                Molina Garrido MJ. Aproximación al cáncer de próstata resistente
                a la castración metastásico en el paciente anciano [internet].
                Barcelona: Méderic Ediciones; 2016. ISBN 978-84-608-9014-0.
                Disponible en: http://www.pacienteancianorc.com2016.
              </p>
              <p>
                Molina-Garrido MJ, Soriano Rodríguez MC, Guillén-Ponce C. What
                is the role of the comprehensive geriatric assessment in
                Geriatric Oncology?. Rev Esp Geriatr Gerontol. 2019;54(1):27-33.
              </p>
              <p>
                Molina-Garrido MJ, Guillén-Ponce C. Use of geriatric assessment
                and screening tools of frailty in elderly patients with prostate
                cancer. Aging Male. 2017;20(2):102-9.
              </p>
              <p>
                Molina-Garrido MJ, Guillén-Ponce C, Blanco R, et al; Working
                Group on Oncogeriatrics of the Spanish Society of Medical
                Oncology (SEOM). Delphi consensus of an expert committee in
                oncogeriatrics regarding comprehensive geriatric assessment in
                seniors with cancer in Spain. J Geriatr Oncol. 2018;9(4):337-45.
              </p>
              <p>
                Molina-Garrido MJ, Guillén-Ponce C. Development of a
                cancer-specific Comprehensive Geriatric Assessment in a
                University Hospital in Spain. Crit Rev Oncol Hematol.
                2011;77(2):148-61.
              </p>
              <p>
                Molina-Garrido MJ, Pintor de la Maza B. Integral approach to the
                older patient with cancer. Nutr Hosp. 2019 May 17. doi:
                10.20960/nh.02677. [Epub ahead of print].
              </p>
              <p>
                Mohile SG; Velarde C, Hurria A, et al. Geriatric
                assessment-guided care processes for older adults: a Delphi
                consensus of geriatric oncology experts. J Natl Compr Canc Netw.
                2015;13:1120-30.
              </p>
              <p>
                Mohile SG, Dale W, Somerfield MR, et al. Practical Assessment
                and Management of Vulnerabilities in Older Patients Receiving
                Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin
                Oncol. 2018;36(22):2326-47.
              </p>
              <p>
                Nishijima TM, Deal AM, Lund JL, et al. The incremental value of
                a geriatric assessment-derived three-item scale on estimating
                overall survival in older adults with cancer. J Geriatr Oncol.
                2018;9:329-36.
              </p>
              <p>
                Nightingale G, Schartz R, Kchur E, et al. Clinical pharmacology
                of oncology agents in older adults: A comprehensive review of
                how chronologic and functional age can influence
                treatment-related effects. J Geriatr Oncol. 2019;10:4-30.
              </p>
              <p>
                <a
                  href="https://www.nccn.org/professionals/physician_gls/pdf/senior.pdf"
                  >National Comprehensive Cancer Network. Older Adult Oncology
                  (Version 1.2019) (accessed June 6, 2019).</a
                >
              </p>
              <p>
                Ǿrum M, Jensen K, Gregersen M, et al. Impact of comprehensive
                geriatric assessment on short-term mortality in older patients
                with cancer- a follow-up study. Eur J Cancer. 2019;116:27-34.
              </p>
              <p>
                Puts MTE, Hus T, Mariano C, et al. Clinical and
                Cost-effectiveness of a Comprehensive geriatric assessment and
                management for Canadian elders with Cancer-the 5C study: a study
                protocol for a randomised controlled phase III trial. BMJ Open.
                2019;9:e024485.
              </p>
              <p>
                O’Donovan A, Mohile SG, Leech M. Expert consensus panel
                guidelines on geriatric assessment in oncology. Eur J Cancer
                Care (Engl). 2015 Jul;24(4):574-89.
              </p>
              <p>
                Pamoukdjian F, Paillaud E, Zelek L, et al. Measurement of gait
                speed in older adults to identify complications associated with
                frailty: A systematic review. J Geriatr Oncol. 2015;6(6):484-96.
              </p>
              <p>
                Papamichael D, Renfro LA, Matthaiou C, et al. Validity of
                Aduvant! Online in older patients with stage III colon cancer
                based on 2967 patients from the ACCENT database. J Geriatr
                Oncol. 2016;7:422-29.
              </p>
              <p>
                Petit-Monéger A, Raifray M, Soubeyran P, et al. Detection of
                frailty in elderly cancer patients: improvement of the G8
                screening test. J Geriatr Oncol. 2016;7(2):99-107.
              </p>
              <p>
                Pope D, Ramesh H, Gennari R, et al. Pre-operative assessment of
                cancer in the elderly (PACE): a comprehensive assessment of
                underlying characteristics of elderly cancer patients prior to
                elective surgery. Surg Oncol. 2006;15:189-97.
              </p>
              <p>
                Puts MT, Monette J, Girre V, et al. Are frailty markers useful
                for predicting treatment toxicity and mortality in older newly
                diagnosed cancer patients?. Results from a prospective pilot
                study. Crit Rev Oncol Hematol. 2011;78:138-49.
              </p>
              <p>
                Prithviraj GK, Koroukian S, Margevicius S, et al. Patient
                characteristics associated with polypharmacy and inappropriate
                prescribing of medicationd among older adults with cancer. J
                Geriatr Oncol. 2012;3:228-37.
              </p>
              <p>
                Puts MT, Hardt J, Monette J, et al. Use of geriatric assessment
                for older adults in the oncology setting: a systematic review. J
                Natl Cancer Inst. 2012;104(15):1133-63.
              </p>
              <p>
                Puts MT, Santos B, Hardt J, et al. An update on a systematic
                review of the use of geriatric assessment for older adults in
                oncology. Ann Oncol. 2014;25(2):307-15.
              </p>
              <p>
                Renfro LA, Grothey A, Xue Y, et al. ACCENT-based web calculators
                to predict recurrence and overall survival in stage III colon
                cancer. J Natl Cancer Inst. 2014:106.
              </p>
              <p>
                Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric
                assessment adds information to Eastern Cooperative Oncology
                Group perfomance status inelderly cancer patients: an Italian
                Group for Geriatric Oncology Study. J Clin Oncol.
                2002;20(2):494-502.
              </p>
              <p>
                Rowbottom L, Loucks A, Jin R, et al. Performance of the
                Vulnerable Elders Survey 13 screening tool in identifying cancer
                treatment modification after geriatric assessment in
                pre-treatment patients: A retrospective analysis. J Geriatr
                Oncol. 2019;10:229-34.
              </p>
              <p>
                Soubeyran P, Terret C, Bellera C. Role of geriatric intervention
                in the treatment of older patients with cancer: rationale and
                design of a phase III multicenter trial. BMC Cancer.
                2016;16:932.
              </p>
              <p>
                Schiller JH, Harrington D, Belani CP, et al. Comparison of four
                chemotherapy regimens for advanced non-small-cell lung cancer. N
                Engl J Med. 2002;346(2):92-8.
              </p>
              <p>
                Sabatier R, Nicolas E, Paciencia M, et al. Nivolumab in routine
                practice for older patients with advanced or metastatic
                non-small cell lung cancer. J Geriatr Oncol. 2018;9(5):494-500.
              </p>
              <p>
                Saliba D, Elliott M, Rubenstein LZ, et al. The Vulnerable Elders
                Survey: a tool for identifying vulnerable older people in the
                community. J Am Geriatr Soc. 2001;49(12):1691-99.
              </p>
              <p>
                Sogaard M, Thomsen RW, Bossen KS, et al. The impact of
                comorbidity on cancer survival: a review. Clin Epidemiol.
                2013;5(suppl 1):3-29.
              </p>
              <p>
                Studenski S, Perera S, Patel K, et al. Gait speed and survival
                in older adults. JAMA. 2011;305:50-58.
              </p>
              <p>
                Schmidt H, Boese S, Lampe K, et al. Trans sectoral care of
                geriatric cancer patients based on comprehensive geriatric
                assessment and patient-reported quality of life- Results of a
                multicenter study to develop and pilot test a patient-centered
                interdisciplinary care concept for geriatric oncology patients
                (PIVOG). J Geriatr Oncol. 2017;8:262-70.
              </p>
              <p>
                Schulkes KJ, Hamaker ME, van den Bos F, et al. Relevance of a
                Geriatric Assessment for Elderly Patients With Lung Cancer-A
                Systematic Review. Clin Lung Cancer. 2016;17(5):341-49.
              </p>
              <p>
                Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence
                in the United States: burdens upon an aging, changing nation. J
                Clin Oncol. 2009;27(17):2758-65.
              </p>
              <p>
                Soto-Perez-de-Celis E, Li D, Yuan Y, et al. Functional versus
                chronological age: geriatric assessments to guide decision
                making in older patients with cancer. Lancet Oncol.
                2018;19:e305-16.
              </p>
              <p>
                Soto-Pérez-de-Celis E, de Glas N, Hsu T, et al. Global geriatric
                oncology: achievements and challenges. J Geriatr Oncol.
                2017;8(5):374-86.
              </p>
              <p>
                Soubeyran P, Bellera C, Goyaard J, et al. Screening for
                vulnerability in older cancer patients: the ONCODAGE prospectiv
                e multicenter cohort study. PLoS One. 2014;9(12):e115060.
              </p>
              <p>
                Soubeyran P, Fonck M, Blanc-Bisson C, et al. Predictors of early
                death risk in older patients treated with first-line
                chemotherapy for cancer. J Clin Oncol. 2012;30(15):1829-34.
              </p>
              <p>
                van Walree IC, Scheepers E. van Huis-Tanja LH, et al. A
                systematic review on the association of the G8 with geriatric
                assessment, prognosis and course of treatment in older patients
                with cancer. J Geriatr Oncol,
                ,https://doi.org/10.1016/j.jgo.2019.04.016.
              </p>
              <p>
                Welaya K, Loh KP, Messing S, et al. Geriatric assessment and
                treatment outcomes in older adults with cancer receiving immune
                checkpoint inhibitors. J Geriatr Oncol,
                https://doi.org/10.1016/j.jgo.2019.05.021.
              </p>
              <p>
                Weiss Wiesel TR, Nelson CJ, Tew WP, et al. The relationship
                between age, anxiety, and depression in older adults with
                cancer. Psychooncology. 2015;24:712-17.
              </p>
              <p>
                Wynter-Bluth V, Moorthy K. Prehabilitation: preparing patients
                for surgery. BMJ. 2017;358:j3702.
              </p>
              <p>
                Williams GR, Mackenzie A, Magnuson A, et al. Comorbidity in
                older adults with cancer. J Geriatr Oncol. 2016;7:249-57.
              </p>
              <p>
                Wildiers H, Heeren P, Puts M, et al. International society of
                geriatric oncology consensus on geriatric assessment in older
                patients with cancer. J Clin Oncol. 2014;32:2595-603.
              </p>
              <p>
                <a
                  href="https://seer.cancer.gov/csr/1975_2015/results_merged/topic_age_dist.pdf"
                  target="_blank"
                  >SEER Cancer Statistics Review 1975-2015</a
                >
              </p>
            </div>
          </div>
        </div>
        <br />

        <div class="ico-cabecera">
          <div class="ico-narrow-content">
            <div class="pager">
              <h3 class="text-center"><br /></h3>
            </div>
          </div>
        </div>
      </div>
    </div>

    <!-- jQuery -->
    <script src="js/jquery.min.js"></script>
    <!-- jQuery Easing -->
    <script src="js/jquery.easing.1.3.js"></script>
    <!-- Bootstrap -->
    <script src="js/bootstrap.min.js"></script>
    <!-- Carousel -->
    <script src="js/owl.carousel.min.js"></script>
    <!-- Stellar -->
    <script src="js/jquery.stellar.min.js"></script>
    <!-- Waypoints -->
    <script src="js/jquery.waypoints.min.js"></script>
    <!-- Counters -->
    <script src="js/jquery.countTo.js"></script>

    <!-- MAIN JS -->
    <script src="js/main.js"></script>
  </body>
</html>
